Financhill
Back

Elevation Oncology Stock Predictions

Elevation Oncology Stock Forecast

  • Is Elevation Oncology Stock Undervalued?
    The current Elevation Oncology [ELEV] share price is $0.38. The Score for ELEV is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • ELEV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Elevation Oncology Stock Go Up Next Year?

Data Unavailable

Elevation Oncology Stock Rating

Data Unavailable

Elevation Oncology Stock Price History

Is ELEV stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ELEV is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
elevationoncology.com

52-Week Data

52-Week High:
3.36
52-Week Low:
0.22

Prediction Charts

Market Cap:
22.6M
Price in USD:
0.38
Volume:
801.9K
Beta:
1.46

Technical Analysis

SMA50:
0.33
SMA100:
0.43
SMA200:
0.53
52-Wk Change:
-88.61%

Stock Predictions

  • Is Elevation Oncology stock public?
    Yes, Elevation Oncology is a publicly traded company.
  • What is the Elevation Oncology stock quote today?
    The Elevation Oncology stock price is 0.38 USD today.
  • How to buy Elevation Oncology stock online?
    You can buy Elevation Oncology shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-27 0.32 0.31 0.32 0.30
May-28 0.30 0.30 0.31 0.30
May-29 0.31 0.31 0.32 0.30
May-30 0.31 0.30 0.31 0.30
Jun-2 0.30 0.31 0.32 0.29
Jun-3 0.30 0.30 0.32 0.30
Jun-4 0.30 0.30 0.32 0.30
Jun-5 0.30 0.31 0.32 0.30
Jun-6 0.30 0.32 0.33 0.30
Jun-9 0.39 0.38 0.40 0.38
Jun-10 0.38 0.38 0.39 0.37
Jun-11 0.38 0.38 0.38 0.38
Jun-12 0.38 0.38 0.38 0.38
Jun-13 0.38 0.38 0.39 0.38

Elevation Oncology Earnings

Data Unavailable

Elevation Oncology Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.05 per share, an increase this year of $0.12 per share, and an increase next year of $0.33 per share.

* Elevation Oncology stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.